Citius Pharmaceuticals, Inc.

NASDAQ:CTXR

0.5481 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011
Operating Activities:
Net Income -32.543-33.641-23.054-17.548-15.562-12.537-10.385-8.296-2.902-1.272-0.031-0.022-0.026
Depreciation & Amortization 0.1940.180.1650.1520.0010.0020.0030.00100000
Deferred Income Tax 0.5760.576-0.16700-0.4500.84400000
Stock Based Compensation 6.6173.9061.4550.8030.7160.780.9870.7320.4860.47000
Change In Working Capital -4.0060.24-2.717-0.8672.1960.510.1160.6680.3630.1650.0110.0020.006
Accounts Receivables 00000.818-0.8180000000
Inventory 0000-0.81800000000
Accounts Payables 1.762-0.112-0.579-0.8571.140.971-0.3070.1050.45300.011-0.0010.001
Other Working Capital -5.7680.351-2.138-0.011.056-0.4610.4220.563-0.090.165-0.0010.0030.005
Other Non Cash Items 0.1020.3780.0680.5290.2120.3771.3120.15-0.332-0.0680.1030-0.026
Operating Cash Flow -29.06-28.361-24.25-16.931-12.438-11.318-7.971-5.9-2.385-0.705-0.021-0.02-0.021
Investing Activities:
Investments In Property Plant And Equipment 00-40.007-0.00200-0.002000000
Acquisitions Net 00000000.25600000
Purchases Of Investments 0000000000000
Sales Maturities Of Investments 0000000000000
Other Investing Activites 00-0.0400000.256000-00
Investing Cash Flow 00-40.007-0.00200-0.0020.256000-00
Financing Activities:
Debt Repayment 00-0.173-0.16500-4.21-0.600-0.0300
Common Stock Issued 13.798089.43115.57711.12416.1736.6735.4281.5090000
Common Stock Repurchased 0000000000000
Dividends Paid 0000000000000
Other Financing Activities 0.031031.2137.4860.0231.1254.210.4351.5092.2560.0510.020.018
Financing Cash Flow 13.8290120.47122.89811.14817.29810.8835.2631.5092.2560.020.020.018
Other Information:
Effect Of Forex Changes On Cash 0000000000000
Net Change In Cash -15.231-28.36156.2135.966-1.295.982.91-0.382-0.8761.5510.054-0-0.002
Cash At End Of Period 26.48141.71270.07313.867.8949.1843.2040.2940.6761.6050.05400